Frontline ALK TKIs in NSCLC: The ALEX Study

Centering discussion on clinical trial data in ALK+ NSCLC, panelists highlight the frontline use of alectinib in the ALEX study.

Related Videos
Experts on renal cell carcinoma
Experts on renal cell carcinoma
Experts on renal cell carcinoma
Bradley McGregor, MD, an expert on renal cell carinoma
Experts on renal cell carcinoma
Experts on renal cell carcinoma
Experts on renal cell carcinoma
Expert on endoemtrial cancer
Expert on endometrial cancer
Related Content